Industry Seeks Reforms To FDA Humanitarian Device Exemption Program
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is calling for legislative and regulatory reforms to the rare-disease-focused humanitarian device exemption FDA approval pathway